Case Reports in Oncological Medicine

Wiley

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

Case Reports in Oncological Medicine is an open-access journal published by Wiley in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 870 USD. Declared review time at DOAJ: 16 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Wiley
ISSN
2090-6706 · 2090-6714
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
870 USD
Articles in DOAJ
976
Declared review time
16 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2011-09-21
Indexing
DOAJ
APC
870 USD
Declared review time (DOAJ)
16 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

976

Most recent article

last month

Average review time (journal-declared via DOAJ)

16weeks

Works in OpenAlex

975

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

26

i10-index

271

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2026-03-12
Added to DOAJ
2011-09-21
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
98%
ORCID iDs in current deposits
98%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101581035
Classification2

Subjects (DOAJ)

Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens

LCC codes

RC254-282

Subject areas

  • Metastasis and carcinoma case studies
  • Sarcoma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Sarcoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Cancer Diagnosis and Treatment
  • Cancer Diagnosis and Treatment
Show all subjects (75)
  • Lymphoma Diagnosis and Treatment
  • Lymphoma Diagnosis and Treatment
  • Cardiac tumors and thrombi
  • Neuroendocrine Tumor Research Advances
  • Breast Lesions and Carcinomas
  • Cancer and Skin Lesions
  • Cancer and Skin Lesions
  • Neuroendocrine Tumor Research Advances
  • Cardiac tumors and thrombi
  • Cardiac tumors and thrombi
  • Viral-associated cancers and disorders
  • Cancer Immunotherapy and Biomarkers
  • Cancer Immunotherapy and Biomarkers
  • Metastasis and carcinoma case studies
  • Metastasis and carcinoma case studies
  • Multiple and Secondary Primary Cancers
  • Brain Metastases and Treatment
  • Lung Cancer Research Studies
  • Lung Cancer Research Studies
  • Brain Metastases and Treatment
  • Brain Metastases and Treatment
  • Vascular Tumors and Angiosarcomas
  • Vascular Tumors and Angiosarcomas
  • Testicular diseases and treatments
  • Neuroblastoma Research and Treatments
  • Neuroblastoma Research and Treatments
  • Bone Tumor Diagnosis and Treatments
  • Renal cell carcinoma treatment
  • Head and Neck Cancer Studies
  • Ovarian cancer diagnosis and treatment
  • Chronic Lymphocytic Leukemia Research
  • Renal cell carcinoma treatment
  • Chronic Lymphocytic Leukemia Research
  • Lung Cancer Diagnosis and Treatment
  • Colorectal Cancer Treatments and Studies
  • Colorectal Cancer Treatments and Studies
  • Neuroendocrine Tumor Research Advances
  • CNS Lymphoma Diagnosis and Treatment
  • CNS Lymphoma Diagnosis and Treatment
  • Bone Tumor Diagnosis and Treatments
  • Viral-associated cancers and disorders
  • CNS Lymphoma Diagnosis and Treatment
  • Bone Tumor Diagnosis and Treatments
  • Viral-associated cancers and disorders
  • Ear and Head Tumors
  • Glioma Diagnosis and Treatment
  • Vascular Tumors and Angiosarcomas
  • Glioma Diagnosis and Treatment
  • Ear and Head Tumors
  • Ovarian cancer diagnosis and treatment
  • Ovarian cancer diagnosis and treatment
  • Pancreatic and Hepatic Oncology Research
  • Gastrointestinal Tumor Research and Treatment
  • Renal cell carcinoma treatment
  • Pancreatic and Hepatic Oncology Research
  • Pancreatic and Hepatic Oncology Research
  • Intraperitoneal and Appendiceal Malignancies
  • Gastric Cancer Management and Outcomes
  • Cutaneous Melanoma Detection and Management
  • Salivary Gland Tumors Diagnosis and Treatment
  • Breast Lesions and Carcinomas
  • Salivary Gland Tumors Diagnosis and Treatment
  • Cancer and Skin Lesions
  • Breast Lesions and Carcinomas
  • Testicular diseases and treatments
  • Testicular diseases and treatments
  • Nonmelanoma Skin Cancer Studies

Keywords (DOAJ)

  • cancer
  • oncology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: